A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
BeiGene
Sunnybrook Health Sciences Centre
DNAtrix, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.